Skip to main content

Crewe Advisors LLC

Position in NVS — Novartis AG

CIK 1730033 SALT LAKE CITY, UT

Position in NVS

as of Jun 30, 2026 · filed Jul 24, 2026
Position Value
$32,284
+$818 QoQ
Shares Held
206
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,463
of 1,603 holders
Holding Since
Sep 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Crewe Advisors LLC holds $5,785,083 across 15 Drug Manufacturers - General names. NVS ranks #11 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVS

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $32,284 206
2026-03-31 $31,466 206
2025-12-31 $28,401 206
2025-09-30 $105,413 822
2025-06-30 $93,782 775
2025-03-31 $86,397 775
2024-12-31 $75,415 775
2024-09-30 $89,140 775
2024-06-30 $82,506 775
2024-03-31 $123,330 1,275
2023-09-30 $109,499 1,075
2023-06-30 $108,478 1,075
2023-03-31 $117,576 1,278
2022-12-31 $75,479 832
2022-09-30 $50,318 662
2022-06-30 $55,958 662
2022-03-31 $40,277 459
2021-12-31 $40,148 459
2021-09-30 $4,825 59
2021-06-30 $5,383 59
2021-03-31 $5,043 59
2020-09-30 $9,391 108